---

Related Articles:

Multiple bone metastases from glioblastoma multiforme without local brain relapse: a case report and review of the literature.

2013-01-01

[Tumori 99(5) , e237-40, (2013)]

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma.

2013-01-01

[J. Transl. Med. 11 , 38, (2013)]

Good clinical activity and favorable toxicity profile of once weekly bortezomib, fotemustine, and dexamethasone (B-MuD) for the treatment of relapsed multiple myeloma.

2013-02-01

[Am. J. Hematol. 88(2) , 102-6, (2013)]

Fotemustine in the treatment of brain primary tumors and metastases.

1994-01-01

[Cancer Invest. 12(4) , 414-20, (1994)]

Proton inactivation of melanoma cells enhanced by fotemustine.

2011-02-01

[Radiat. Prot. Dosimetry 143(2-4) , 503-7, (2011)]